(3S)-3-[[(2S)-2-[[(2S,3S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[(2-acetamidoacetyl)amino]-3-hydroxy-butanoyl]amino]-5-guanidino-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[[(1S)-1-[[(3S,6S,9S,12S,21S)-21-[[(1R)-2-[[(1S)-1-[[(1S)-3-amino-1-carbamoyl-3-oxo-propyl]carbamoyl]-4-guanidino-butyl]amino]-2-oxo-1-(sulfanylmethyl)ethyl]carbamoyl]-9-benzyl-3,6,12,21-tetramethyl-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclohenicos-16-en-12-yl]carbamoyl]-4-guanidino-butyl]amino]-4-oxo-butanoic acid

ID: ALA4550774

Chembl Id: CHEMBL4550774

PubChem CID: 155555125

Max Phase: Preclinical

Molecular Formula: C87H139N27O22S

Molecular Weight: 1947.30

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(C)=O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@]1(C)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)CC

Standard InChI:  InChI=1S/C87H139N27O22S/c1-11-45(3)65(112-79(133)66(46(4)12-2)111-72(126)55(28-23-37-97-84(92)93)104-80(134)67(49(7)115)110-63(119)43-99-50(8)116)78(132)107-58(40-52-30-32-53(117)33-31-52)74(128)106-60(42-64(120)121)75(129)103-56(29-24-38-98-85(94)95)77(131)114-87(10)35-21-16-14-13-15-20-34-86(9,113-70(124)48(6)100-69(123)47(5)101-73(127)59(108-81(87)135)39-51-25-18-17-19-26-51)82(136)109-61(44-137)76(130)102-54(27-22-36-96-83(90)91)71(125)105-57(68(89)122)41-62(88)118/h13-14,17-19,25-26,30-33,45-49,54-61,65-67,115,117,137H,11-12,15-16,20-24,27-29,34-44H2,1-10H3,(H2,88,118)(H2,89,122)(H,99,116)(H,100,123)(H,101,127)(H,102,130)(H,103,129)(H,104,134)(H,105,125)(H,106,128)(H,107,132)(H,108,135)(H,109,136)(H,110,119)(H,111,126)(H,112,133)(H,113,124)(H,114,131)(H,120,121)(H4,90,91,96)(H4,92,93,97)(H4,94,95,98)/b14-13-/t45-,46-,47-,48-,49+,54-,55-,56-,57-,58-,59-,60-,61-,65-,66-,67-,86-,87-/m0/s1

Standard InChI Key:  QKBJFIXPMIIULT-ANUUCGHESA-N

Alternative Forms

  1. Parent:

    ALA4550774

    ---

Associated Targets(Human)

EIF4E Tchem Eukaryotic translation initiation factor 4E/Eukaryotic translation initiation factor 4E-binding protein 1 (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EIF4E Tchem EIF4E/EIF4G1 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1947.30Molecular Weight (Monoisotopic): 1946.0309AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Gallagher EE, Song JM, Menon A, Mishra LD, Chmiel AF, Garner AL..  (2019)  Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.,  62  (10): [PMID:31033289] [10.1021/acs.jmedchem.9b00068]

Source